Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Heli Vajavaara1, Frida Ekeblad2, Harald Holte3

  • 1Research Program Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki.

Haematologica
|March 25, 2021
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos